logo

Pfizer Inc. (PFE) Stock: Navigating Drops and Gains

TOST Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Pfizer Inc.’s current trading price is -18.17% away from its 52-week high, while its distance from the 52-week low is 20.75%. The stock’s price range during this period has varied between $25.20 and $37.19. The company, active in the Healthcare sector, saw a trading volume of around 42.18 million for the day, considerably higher average daily volume of 36.71 million observed over the last three months.

The market performance of Pfizer Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $37.19 on 08/21/23, with the lowest value for the same timeframe being $25.20, recorded on 04/26/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

How Financial Performance Impacts Market Capitalization

Pfizer Inc. (PFE) has experienced a quarterly rise of 9.86% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 172.43B and boasts a workforce of 88000 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 28.01, with a change in price of +2.06. Similarly, Pfizer Inc. recorded 37,638,418 in trading volume during the last 100 days, posting a change of +7.26%.

How PFE’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PFE stands at 0.75. Similarly, the long-term debt-to-equity ratio is also 0.66.

PFE Stock Stochastic Average

As of today, the raw stochastic average of Pfizer Inc. over the past 50 days is 76.23%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 73.85%. Additionally, the Stochastic %K and %D values for the company were 76.44% and 83.16%, respectively, over the past 20 days.

PFE Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant gain of 5.70% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 11.51%. Over the past 30 days, the price of PFE has fallen by 9.86%. And in the last five days, it has fallen by -1.10%.

Most Popular